Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003783priorityCriticalpatent/ECSP003783A/es
Publication of ECSP003783ApublicationCriticalpatent/ECSP003783A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Este invento se refiere al compuesto de la fórmula que es la 2-(3,5-bis-trifluorometil-fenil)¿N-metil-N-(6-morfolin-4-il-4-o-tolil-piridin-3-il)-isobutiramida . Se ha encontrado que este compuesto tiene una alta afinidad al receptor NK-1 y es por tanto útil en el tratamiento de enfermedades relacionadas con este receptor.
Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2(1h)-indol-2-ona (=ziprasidona), su preparacion y su uso como antagonista de la dopamina.
2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1lambda6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide